Time and money address clinical meaningfulness better than points on clinical outcome assessments particularly with disease modification in early disease

We only have this paper's title and publication details.

Observational analysis reveals that time and costs better indicate clinical meaningfulness in early disease, suggesting better evaluation approaches.